Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen
about
A vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types.Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activityHIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodiesA 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunityExpression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-FcEvaluation of the potency of the anti-idiotypic antibody Ab2/3H6 mimicking gp41 as an HIV-1 vaccine in a rabbit prime/boost studyEbolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccinesImmunization of rabbits with highly purified, soluble, trimeric human immunodeficiency virus type 1 envelope glycoprotein induces a vigorous B cell response and broadly cross-reactive neutralization.Identification of Non-HIV Immunogens That Bind to Germline b12 Predecessors and Prime for Elicitation of Cross-clade Neutralizing HIV-1 Antibodies.Potential vaccines and post-exposure treatments for filovirus infections.A novel synthetic bipartite carrier protein for developing glycotope-based vaccines.Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity.Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein.
P2860
Q33572691-D78F77C0-406B-4825-B00C-EBD0BE543CF3Q33826951-DED8DBBC-C9F8-4E56-9D94-74CBC4208AFEQ33869882-CE43D8CE-4436-493D-9911-54DD1DB2B416Q33904997-562EC57B-E5A2-47EC-A0B2-C2C3CFD13851Q33984231-0F415056-668A-4A74-AD86-2683758683F3Q34312108-4494FC34-AB97-41B7-829A-6CA28962F16BQ34540207-462042ED-002B-4269-A8D7-04D195B9D024Q34548282-34FA4976-2586-4309-905C-6C5146F70380Q34761889-9E9D0745-8211-410B-B42B-4507937CE8DAQ35063993-C366F5B6-90A0-4D6A-8C1D-3DD831A7686EQ35171701-06DAF7E6-DFB4-48AA-93E3-0CAE4B0B652EQ35641314-348F57D0-AFE6-4029-9F59-59C42581C872Q36404178-FA3232C7-65CE-44A9-A3B0-C9CB2BA89FE1Q36442488-A021DA4B-6534-4500-9DF6-B6E8E87B2B8BQ37366744-757E8FCD-D1C0-4989-BE2C-3F3AF0BBA719Q38072056-F2666AAB-15A0-45D4-A7FA-A7029CD1BA6CQ39102732-60AD1C9E-877F-4E64-8C1D-E272B3587BB2Q39614628-68625781-1713-4C27-8ADC-B50C71A86C77Q42197619-C57D4368-019C-48EC-9DB2-4F4A23D0897F
P2860
Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cross-reactive HIV-1-neutraliz ...... ged half-life of the immunogen
@ast
Cross-reactive HIV-1-neutraliz ...... ged half-life of the immunogen
@en
type
label
Cross-reactive HIV-1-neutraliz ...... ged half-life of the immunogen
@ast
Cross-reactive HIV-1-neutraliz ...... ged half-life of the immunogen
@en
prefLabel
Cross-reactive HIV-1-neutraliz ...... ged half-life of the immunogen
@ast
Cross-reactive HIV-1-neutraliz ...... ged half-life of the immunogen
@en
P2093
P2860
P1433
P1476
Cross-reactive HIV-1-neutraliz ...... ged half-life of the immunogen
@en
P2093
Dimiter S Dimitrov
Marie K Mankowski
Mei-Yun Zhang
Roger G Ptak
Yanping Wang
P2860
P304
P356
10.1016/J.VACCINE.2008.11.083
P407
P577
2008-12-10T00:00:00Z